Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-04-11 | 2024-04-18 | 224886 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-04-18 | 218952 |
| TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2024-01-11 | 2024-04-18 | 215701 |
| TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2024-02-15 | 2024-04-18 | 219684 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2023-11-03 | 2024-04-18 | 209136 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2024-03-07 | 2024-04-18 | 221543 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2024-02-08 | 2024-04-18 | 218974 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| TEVA-TOPISONE | 0.05% | LOTION | Actual shortage | 2024-04-18 | 2024-04-18 | 225480 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-04-25 | 198309 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Actual shortage | 2024-02-29 | 2024-04-25 | 220983 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Actual shortage | 2024-02-08 | 2024-04-25 | 218977 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Actual shortage | 2023-10-19 | 2024-04-25 | 207545 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Actual shortage | 2023-07-27 | 2024-04-25 | 200307 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-25 | 2024-04-25 | 226177 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-02-01 | 2024-04-25 | 218145 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-01-25 | 2024-04-25 | 217240 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-08-03 | 2024-04-25 | 200864 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-21 | 2024-04-25 | 222938 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |